P50AR080594
Project Grant
Overview
Grant Description
Acne: A Disease of Lipid Metabolism, Microbiome, and the Immune Response - Abstract / Project Summary
Overall, the goal of the UCLA/UCSD Acne Center for Research Translation (ACNE CORT) is to bring together scientists with expertise in different aspects of microbiology, lipid metabolism, and immunology to engage in translational research. The aim is to study the interaction between the microbiota, lipid metabolism, and the host immune response in acne.
Cutibacterium acnes is the dominant bacterium of the pilosebaceous unit (PSEBU), which is the initial site where acne lesions develop. It is considered to be one of the key contributing factors in the pathogenesis of acne. The UCLA/UCSD research project is based on recent findings using transcriptomics, metagenomics, and lipidomics. These findings establish the goal of linking together these diverse biological responses into a model that may explain the pathogenesis of acne.
The UCLA/UCSD research project, titled "Acne: A Disease of Lipid Metabolism, Microbiome, and the Immune Response" and led by Modlin and Gallo, will initially focus on studying the role of TREM2 macrophages and adipogenic fibroblasts in the pathogenesis of acne. Preliminary data from single-cell RNA sequencing (scRNA-seq) and spatial-sequencing have identified these two cell populations as over-represented in acne lesions. The gene programs expressed by these cells reflect their link to altered lipid metabolism.
The project investigators will obtain acne biopsy specimens from Hata and Kim. They will then address the link between the immune response in acne lesions and the microbiome and lipid metabolism. The research project will be supported by a UCLA Bioinformatics Core (Pellegrini, Yang) to analyze scRNA-seq and spatial-sequencing data of acne lesions. A UCSD Microbiology and Metagenomics Core (Gallo, O'Neill) will isolate and characterize C. acnes strains, while lipidomics analysis (Bensinger, UCLA) will be performed on biopsy specimens and key cell types derived in vitro.
Ultimately, the Bioinformatics Core will use mergeomics to combine data from transcriptomics, metagenomics, and lipidomics to create a network model of the pathogenesis of acne. The Administrative Core will facilitate research interactions between the projects through research seminars, an enrichment program, and advisory board meetings. Additionally, a pilot and feasibility project program will extend the research base. The resources and environment at UCLA/UCSD, including core facilities and the UCLA and UCSD Clinical and Translational Science Awards (CTSA) program centers, will be utilized. Furthermore, mentoring programs for medical and graduate students, postdoctoral fellows, dermatology trainees, and junior faculty will be incorporated.
The proposed studies will provide new insights into how lipid metabolism and the skin microbiome shape cutaneous immune responses, contributing to inflammation. This research has the potential for intervention in skin disease.
Overall, the goal of the UCLA/UCSD Acne Center for Research Translation (ACNE CORT) is to bring together scientists with expertise in different aspects of microbiology, lipid metabolism, and immunology to engage in translational research. The aim is to study the interaction between the microbiota, lipid metabolism, and the host immune response in acne.
Cutibacterium acnes is the dominant bacterium of the pilosebaceous unit (PSEBU), which is the initial site where acne lesions develop. It is considered to be one of the key contributing factors in the pathogenesis of acne. The UCLA/UCSD research project is based on recent findings using transcriptomics, metagenomics, and lipidomics. These findings establish the goal of linking together these diverse biological responses into a model that may explain the pathogenesis of acne.
The UCLA/UCSD research project, titled "Acne: A Disease of Lipid Metabolism, Microbiome, and the Immune Response" and led by Modlin and Gallo, will initially focus on studying the role of TREM2 macrophages and adipogenic fibroblasts in the pathogenesis of acne. Preliminary data from single-cell RNA sequencing (scRNA-seq) and spatial-sequencing have identified these two cell populations as over-represented in acne lesions. The gene programs expressed by these cells reflect their link to altered lipid metabolism.
The project investigators will obtain acne biopsy specimens from Hata and Kim. They will then address the link between the immune response in acne lesions and the microbiome and lipid metabolism. The research project will be supported by a UCLA Bioinformatics Core (Pellegrini, Yang) to analyze scRNA-seq and spatial-sequencing data of acne lesions. A UCSD Microbiology and Metagenomics Core (Gallo, O'Neill) will isolate and characterize C. acnes strains, while lipidomics analysis (Bensinger, UCLA) will be performed on biopsy specimens and key cell types derived in vitro.
Ultimately, the Bioinformatics Core will use mergeomics to combine data from transcriptomics, metagenomics, and lipidomics to create a network model of the pathogenesis of acne. The Administrative Core will facilitate research interactions between the projects through research seminars, an enrichment program, and advisory board meetings. Additionally, a pilot and feasibility project program will extend the research base. The resources and environment at UCLA/UCSD, including core facilities and the UCLA and UCSD Clinical and Translational Science Awards (CTSA) program centers, will be utilized. Furthermore, mentoring programs for medical and graduate students, postdoctoral fellows, dermatology trainees, and junior faculty will be incorporated.
The proposed studies will provide new insights into how lipid metabolism and the skin microbiome shape cutaneous immune responses, contributing to inflammation. This research has the potential for intervention in skin disease.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Los Angeles,
California
900958348
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 387% from $1,568,723 to $7,641,573.
Los Angeles University Of California was awarded
Acne: Linking Microbiome, Lipid Metabolism, and Immune Response
Project Grant P50AR080594
worth $7,641,573
from the National Institute of Arthritis and Musculoskeletal and Skin Diseases in September 2022 with work to be completed primarily in Los Angeles California United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.846 Arthritis, Musculoskeletal and Skin Diseases Research.
The Project Grant was awarded through grant opportunity NIAMS Centers of Research Translation (CORT) (P50 - Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 8/20/26
Period of Performance
9/1/22
Start Date
8/31/27
End Date
Funding Split
$7.6M
Federal Obligation
$0.0
Non-Federal Obligation
$7.6M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for P50AR080594
Transaction History
Modifications to P50AR080594
Additional Detail
Award ID FAIN
P50AR080594
SAI Number
P50AR080594-1792763555
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NB00 NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases
Funding Office
75NB00 NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases
Awardee UEI
RN64EPNH8JC6
Awardee CAGE
4B557
Performance District
CA-36
Senators
Dianne Feinstein
Alejandro Padilla
Alejandro Padilla
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Health and Human Services (075-0888) | Health research and training | Grants, subsidies, and contributions (41.0) | $3,132,428 | 100% |
Modified: 8/20/26